Moleculin Biotech Inc (MBRX)
2.75
+0.31
(+12.70%)
USD |
NASDAQ |
Sep 27, 16:00
2.72
-0.03
(-1.09%)
After-Hours: 20:00
Moleculin Biotech Net Income (Annual): -29.77M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -29.77M |
| December 31, 2022 | -29.02M |
| December 31, 2021 | -15.89M |
| December 31, 2020 | -17.36M |
| Date | Value |
|---|---|
| December 31, 2019 | -13.20M |
| December 31, 2018 | -11.88M |
| December 31, 2017 | -9.805M |
| December 31, 2016 | -3.926M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-29.77M
Minimum
2023
-13.20M
Maximum
2019
-21.05M
Average
-17.36M
Median
2020
Net Income (Annual) Benchmarks
| Agilent Technologies Inc | 1.24B |
| Seelos Therapeutics Inc | -37.88M |
| Cara Therapeutics Inc | -118.51M |
| Citius Pharmaceuticals Inc | -32.54M |
| NovaBay Pharmaceuticals Inc | -9.64M |